Maropitant Citrate Market Revenue, Insights, Overview, Outlook, Analysis | Valuates Reports

Maropitant Citrate Market

Maropitant citrate is a veterinary medication primarily used to prevent and treat nausea and vomiting in dogs and cats. It is a neurokinin-1 (NK1) receptor antagonist, which works by blocking the action of substance P, a key neurotransmitter involved in the vomiting reflex.Available in tablet form for oral administration and as an injectable solution, maropitant is commonly used for conditions such as motion sickness, gastroenteritis, and chemotherapy-induced vomiting.

The global Maropitant Citrate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-19H18591/Global_Maropitant_Citrate_Market_Research_Report_2024

North American market for Maropitant Citrate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Maropitant Citrate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Maropitant Citrate include Zoetis, ZyVet Animal Health, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

By Type
• Tablets
• Injectable

By Application
• Canine
• Feline

Key Companies
Zoetis, ZyVet Animal Health

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-19H18591/global-maropitant-citrate

Email Id:
Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.